Standout Papers

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised p... 2005 2026 2012 2019 1.7k
  1. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study (2010)
    Karl Swedberg, Michel Komajda et al. The Lancet
  2. Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes (2005)
    Nikos Werner, Katrin Walenta et al. New England Journal of Medicine
  3. Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock (2012)
    Hölger Thiele, Uwe Zeymer et al. New England Journal of Medicine
  4. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial (2010)
    Murray Esler, Henry Krum et al. The Lancet
  5. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) (2005)
    Marcus Flather, Marcelo C. Shibata et al. European Heart Journal
  6. Cardiovascular Disease in Chronic Kidney Disease (2021)
    Joachim Jankowski, Jürgen Floege et al. Circulation
  7. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial (2010)
    Michael Böhm, Karl Swedberg et al. The Lancet
  8. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. (1993)
    Martin Ungerer, Michael Böhm et al. Circulation
  9. Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis (2003)
    Ulrich Laufs, Nikos Werner et al. Circulation
  10. Intravenous Transfusion of Endothelial Progenitor Cells Reduces Neointima Formation After Vascular Injury (2003)
    Nikos Werner, Stefan Junk et al. Circulation Research
  11. Update on Myocarditis (2012)
    Ingrid Kindermann, Christine Barth et al. Journal of the American College of Cardiology
  12. Cardiovascular remodelling in coronary artery disease and heart failure (2014)
    Gerd Heusch, Peter Libby et al. The Lancet
  13. Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon Catheter (2006)
    Bruno Scheller, Christoph Hehrlein et al. New England Journal of Medicine
  14. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial (2013)
    Hölger Thiele, Uwe Zeymer et al. The Lancet
  15. Impact of Remote Telemedical Management on Mortality and Hospitalizations in Ambulatory Patients With Chronic Heart Failure (2011)
    Friedrich Koehler, Sebastian Winkler et al. Circulation
  16. Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure. (1994)
    R. Studer, Hans Reinecke et al. Circulation Research
  17. Predictors of Outcome in Patients With Suspected Myocarditis (2008)
    Ingrid Kindermann, Michael Kindermann et al. Circulation
  18. Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study (2010)
    Luís M. Ruilope, Andrej Dukát et al. The Lancet
  19. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study (2013)
    Henry Krum, Markus P. Schlaich et al. The Lancet
  20. Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension (2011)
    Felix Mahfoud, Markus P. Schlaich et al. Circulation
  21. Renal Sympathetic Denervation Reduces Left Ventricular Hypertrophy and Improves Cardiac Function in Patients With Resistant Hypertension (2012)
    Mathias C. Brandt, Felix Mahfoud et al. Journal of the American College of Cardiology
  22. A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease (2016)
    Gerasimos Filippatos, Stefan D. Anker et al. European Heart Journal
  23. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency (2017)
    Dirk J. van Veldhuisen, Piotr Ponikowski et al. Circulation
  24. Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status (2020)
    Stefan D. Anker, Javed Butler et al. Circulation
  25. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial (2022)
    Felix Mahfoud, David E. Kandzari et al. The Lancet

Immediate Impact

85 by Nobel laureates 36 from Science/Nature 87 standout
Sub-graph 1 of 21

Citing Papers

Ferric Carboxymaltose in Heart Failure with Iron Deficiency
2023 Standout
Myocarditis
2022 Standout
27 intermediate papers

Works of Michael Böhm being referenced

Myopathic Cardiac Genotypes Increase Risk for Myocarditis
2021
Predictors of Outcome in Patients With Suspected Myocarditis
2008 Standout
and 14 more

Author Peers

Author Last Decade Papers Cites
Michael Böhm 38042 14032 11785 1.1k 61.0k
Thomas F. Lüscher 27493 13292 11328 1.1k 61.0k
Dirk J. van Veldhuisen 42486 7636 5629 852 58.8k
Milton Packer 51532 9120 7116 646 63.5k
Martin G. Larson 51911 12342 9801 580 86.7k
Giuseppe Remuzzi 17583 12142 15712 1.3k 92.7k
Stefan D. Anker 26484 7209 8920 720 54.4k
Faı̈ez Zannad 37457 9964 7521 946 55.6k
Christodoulos Stefanadis 20783 7554 4641 1.3k 45.1k
Lars Køber 38013 10184 5849 1.3k 57.2k
James T. Willerson 20757 16670 9139 628 47.0k

All Works

Loading papers...

Rankless by CCL
2026